Profile | GDS2987 / GI_45643130-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 15.1 | 47 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 14.5 | 44 |
GSM215254 | HMVEC_atorvastatin_rep1 | 2.9 | 8 |
GSM215282 | HMVEC_atorvastatin_rep3 | 8.8 | 21 |
GSM215344 | HMVEC_atorvastatin_rep2 | 19.2 | 43 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 2.6 | 5 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 128.1 | 76 |
GSM215298 | PASMC_vehicle_rep2 | 96.6 | 73 |
GSM215310 | PASMC_vehicle_rep3 | 56.3 | 64 |
GSM215311 | PASMC_atorvastatin_rep1 | 97.7 | 74 |
GSM215312 | PASMC_atorvastatin_rep2 | 97.5 | 74 |
GSM215313 | PASMC_atorvastatin_rep3 | 70.1 | 67 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 80.1 | 71 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 118.9 | 76 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 53.7 | 64 |
GSM215327 | PASMC_SLx2119_rep1 | 40.7 | 56 |
GSM215328 | PASMC_SLx2119_rep2 | 10 | 19 |
GSM215329 | PASMC_SLx2119_rep3 | 60.9 | 68 |
GSM215330 | Fibroblasts_vehicle_rep1 | 39.7 | 62 |
GSM215331 | Fibroblasts_vehicle_rep2 | 79.9 | 73 |
GSM215332 | Fibroblasts_vehicle_rep3 | 69.9 | 72 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 87.5 | 74 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 65 | 71 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 73.3 | 72 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 91.8 | 74 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 68.2 | 72 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 81.7 | 73 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 46.3 | 68 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 23.8 | 54 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 28.9 | 56 |